Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
or

Rafael Holdings Inc (RFL)

Rafael Holdings Inc (RFL)
1.3700 x 1 1.8400 x 1
Post-market by (Cboe BZX)
1.6900 +0.0100 (+0.60%) 04/21/25 [NYSE]
1.3700 x 1 1.8400 x 1
Post-market 1.6900 unch (unch) 19:00 ET
Quote Overview for Mon, Apr 21st, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
1.6100
Day High
1.7300
Open 1.6300
Previous Close 1.6800 1.6800
Volume 32,700 32,700
Avg Vol 42,765 42,765
Stochastic %K 33.09% 33.09%
Weighted Alpha -3.91 -3.91
5-Day Change -0.0100 (-0.59%) -0.0100 (-0.59%)
52-Week Range 1.2900 - 2.5000 1.2900 - 2.5000
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 41,854
  • Shares Outstanding, K 24,913
  • Annual Sales, $ 640 K
  • Annual Income, $ -34,410 K
  • EBIT $ -104 M
  • EBITDA $ -104 M
  • 60-Month Beta 0.99
  • Price/Sales 62.58
  • Price/Cash Flow N/A
  • Price/Book 0.55

Options Overview Details

View History
  • Implied Volatility 360.22% ( +169.75%)
  • Historical Volatility 53.88%
  • IV Percentile 90%
  • IV Rank 71.63%
  • IV High 492.63% on 02/20/25
  • IV Low 25.95% on 09/17/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 20
  • Volume Avg (30-Day) 56
  • Put/Call OI Ratio 0.03
  • Today's Open Interest 380
  • Open Int (30-Day) 169

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.5700 +7.64%
on 04/17/25
Period Open: 1.8600
2.1200 -20.28%
on 03/25/25
-0.1700 (-9.14%)
since 03/21/25
3-Month
1.5700 +7.64%
on 04/17/25
Period Open: 2.0700
2.1800 -22.48%
on 01/23/25
-0.3800 (-18.36%)
since 01/21/25
52-Week
1.2900 +31.01%
on 07/12/24
Period Open: 1.7600
2.5000 -32.40%
on 10/14/24
-0.0700 (-3.98%)
since 04/19/24

Most Recent Stories

More News
Rafael Holdings Completes Merger with Cyclo Therapeutics Following Shareholder Approvals

CYTH : 0.7206 (+1.39%)
RFL : 1.6900 (+0.60%)
Rafael Holdings Reports Second Quarter Fiscal 2025 Financial Results

CYTH : 0.7206 (+1.39%)
RFL : 1.6900 (+0.60%)
Rafael Holdings, Inc. Reports First Quarter Fiscal Year 2025 Financial Results and Updates on Planned Merger with Cyclo Therapeutics

Rafael Holdings reports Q1 fiscal 2025 results, anticipates merger with Cyclo Therapeutics, and focuses on Trappsol® Cyclo™ development.Quiver AI SummaryRafael Holdings, Inc. reported its financial...

RFL : 1.6900 (+0.60%)
Rafael Holdings Reports First Quarter Fiscal 2025 Financial Results

RFL : 1.6900 (+0.60%)
Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results

RFL : 1.6900 (+0.60%)
Cyclo Therapeutics Announces Closing of Strategic Investment Through a $2.1 Million Private Placement from Rafael Holdings, Inc. (NYSE:RFL)

Cyclo Therapeutics, Inc. (Nasdaq: CYTH) (“Cyclo Therapeutics” or the “Company”), a clinical stage biotechnology company dedicated to developing life-changing medicines through science and innovation...

CYTH : 0.7206 (+1.39%)
RFL : 1.6900 (+0.60%)
Cornerstone Pharmaceuticals Strengthens Scientific Advisory Board with the Appointment of Distinguished Scholar Jason Locasale, Ph.D.

CRANBURY, N.J., July 06, 2022 (GLOBE NEWSWIRE) -- Cornerstone Pharmaceuticals, Inc. (“Cornerstone” or the “Company”), a company focused on rare cancer...

RFL : 1.6900 (+0.60%)
Cornerstone Pharmaceuticals Announces Published Data on CPI-613® (Devimistat) as an Effective Approach to Targeting Carcinoma Catabolism – UPDATE

Cranbury, N.J., June 16, 2022 (GLOBE NEWSWIRE) -- Cornerstone Pharmaceuticals, Inc. (“Cornerstone” or the “Company”), a company focused on rare cancer...

RFL : 1.6900 (+0.60%)
Cornerstone Pharmaceuticals Announces Published Data on CPI-613® (Devimistat) as an Effective Approach to Targeting Carcinoma Catabolism

Cranbury, N.J., June 16, 2022 (GLOBE NEWSWIRE) -- Cornerstone Pharmaceuticals, Inc. (“Cornerstone” or the “Company”), a company focused on rare cancer...

RFL : 1.6900 (+0.60%)
Rafael Holdings Reports Third Quarter Fiscal 2022 Financial Results

NEWARK, N.J., June 14, 2022 (GLOBE NEWSWIRE) -- Rafael Holdings, Inc. (NYSE: RFL), an early-stage novel cancer and immune metabolism therapeutics...

RFL : 1.6900 (+0.60%)

Business Summary

Rafael Holdings Inc. manufactures metabolic oncology drugs to treat cancer. The company's product pipeline consists of CPI-613, CPI-618, CPI-1826 and CPI-3220 which are in clinical stages. Rafael Holdings Inc. is based in Newark, United States.

See More

Key Turning Points

3rd Resistance Point 1.8633
2nd Resistance Point 1.7967
1st Resistance Point 1.7433
Last Price 1.6900
1st Support Level 1.6233
2nd Support Level 1.5567
3rd Support Level 1.5033

See More

52-Week High 2.5000
Fibonacci 61.8% 2.0378
Fibonacci 50% 1.8950
Fibonacci 38.2% 1.7522
Last Price 1.6900
52-Week Low 1.2900

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro

Info When You Need It Most.

Barchart Premier is one of the most powerful tools in the investment world. Come see why so many subscribers love it — and try it risk-free for 30 days.